EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism

Aysun Şengül, Yusuf Aydemir, Derya Kızılgöz Özaydın, Pınar Akın Kabalak, Yasemin Söyler, Hüsnü Baykal, Muzaffer Onur Turan, Ersin Alkılınç, Fulsen Bozkuş, Pınar Yıldız Gülhan, Celal Satıcı, Sertaç Arslan und 6 weitere

Journal of Pulmonology and Intensive Care · 28.10.2026 · 4 (4) · 111-117

DOI: 10.51271/jopic-0090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pulmonology and Intensive Care, online erschienen am 28.10.2026. Verfasst von Aysun Şengül und 17 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the clinical characteristics, radiological findings, and mortality-related factors in patients with COVID-19-associated pulmonary embolism (PE).

Methods

This multicenter retrospective cohort study analyzed data from 13 tertiary centers and included adult patients with molecularly confirmed SARS-CoV-2 infection and radiologically verified PE.

Results

A total of 112 patients were included (mean age: 59.9±14.1 years), of whom 50% had severe pneumonia. PE and COVID-19 were diagnosed simultaneously in 29.5% of cases. The median interval between COVID-19 diagnosis and PE development was 6 days. Despite standard or intermediate-dose thromboprophylaxis, PE occurred in 42.9% of patients. Computed tomography pulmonary angiography demonstrated predominantly peripheral embolic involvement (58.0%). According to early mortality risk stratification, 5.4% of patients were classified as high risk and 19.6% as intermediate-high risk. The in-hospital and 30-day mortality rates were 7.1% and 12.5%, respectively. Mortality was significantly associated with advanced age, comorbidities, severe pneumonia, thrombocytopenia, elevated lactate dehydrogenase and ferritin levels, high/intermediate-high risk classification, intensive care unit admission, and invasive mechanical ventilation. Multivariate logistic regression identified thrombocytopenia as an independent predictor of 30-day mortality (OR 10.11, 95% CI 1.49-68.92; p=0.01).

Conclusion

PE commonly develops during the early phase of COVID-19 and may occur despite thromboprophylaxis. Early recognition and individualized, risk-adapted anticoagulation strategies are essential.

Zitieren

APA

Şengül, A., Aydemir, Y., Özaydın, D. K., Kabalak, P. A., Söyler, Y., Baykal, H., Turan, M. O., Alkılınç, E., Bozkuş, F., Gülhan, P. Y., Satıcı, C., Arslan, S., Demirkol, M. A., Fazlıoğlu, N., Çapraz, A., Mutlu, P., Aktürk, Ü. A., & Ogan, N. (2026). Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism. Journal of Pulmonology and Intensive Care, 4(4), 111-117. https://doi.org/10.51271/jopic-0090

Vancouver

Şengül A, Aydemir Y, Özaydın DK, Kabalak PA, Söyler Y, Baykal H, et al. Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism. Journal of Pulmonology and Intensive Care. 2026;4(4):111-117. doi:10.51271/jopic-0090

BibTeX
@article{engl2026,
  author = {Şengül, Aysun and Aydemir, Yusuf and Özaydın, Derya Kızılgöz and Kabalak, Pınar Akın and Söyler, Yasemin and Baykal, Hüsnü and Turan, Muzaffer Onur and Alkılınç, Ersin and Bozkuş, Fulsen and Gülhan, Pınar Yıldız and Satıcı, Celal and Arslan, Sertaç and Demirkol, Mustafa Asım and Fazlıoğlu, Nevin and Çapraz, Aylin and Mutlu, Pınar and Aktürk, Ülkü Aka and Ogan, Nalan},
  title = {Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism},
  journal = {Journal of Pulmonology and Intensive Care},
  year = {2026},
  volume = {4},
  number = {4},
  pages = {111--117},
  doi = {10.51271/jopic-0090}
}
Kostenlos starten →